[6-K] Tiziana Life Sciences Ltd. Current Report (Foreign Issuer)

Rhea-AI Filing Summary

Gilat Satellite Networks (NASDAQ/TASE: GILT) filed a Form 6-K stating it will release second-quarter 2025 financial results on Wednesday, 6 Aug 2025. A conference call with CEO Adi Sfadia and CFO Gil Benyamini will begin at 09:30 AM EST / 16:30 IST. Investors may join via webcast (link provided) or dial-in (US 1-888-407-2553; International +972-3-918-0609); the replay will remain accessible for 30 days. The filing contains no preliminary figures, guidance or strategic updates and therefore has no immediate valuation impact. It primarily serves to give the market advance notice of the earnings date and access logistics.

Insights

Financial Analyst

TL;DR: Routine Form 6-K sets Q2 2025 earnings release for Aug 6; no financial data disclosed.

The document is purely procedural, providing the timetable and access details for Gilat’s forthcoming results call. Absent revenue, margin or backlog numbers, it offers limited insight into current performance or valuation. Nonetheless, timely disclosure enables analysts to prepare models and ensures equal access to management commentary. Market reaction is expected to be muted until the actual earnings are published.

Portfolio Manager

TL;DR: Calendar notice only; neutral for portfolio positioning.

No results, guidance or strategic announcements accompany this filing. While the call’s availability underscores solid investor-relations practice, it does not alter the investment thesis or risk profile. I maintain a wait-and-see stance until the Aug 6 print reveals order trends, defense exposure and any impact from Middle East tensions highlighted in the boilerplate risk section.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

July 2025

Commission File Number:  001-38723

Tiziana Life Sciences LTD

(Exact Name of Registrant as Specified in Its Charter)

9^th Floor

107 Cheapside

London

EC2V 6DN

(Address of registrant’s principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒     Form 40-F ☐

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

On July 21, 2025, Tiziana Life Sciences LTD (the “Company”) issued this 6K announcing, compelling immunologic findings from the treatment of a moderate Alzheimer’s Disease (AD) patient with intranasal foralumab.

The Announcement is furnished herewith as Exhibit 99.1 to this Report on Form 6-K. The information in the attached Exhibits 99.1 is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, except as otherwise set forth herein or as shall be expressly set forth by specific reference in such a filing.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	TIZIANA LIFE SCIENCES LTD
Date: July 21, 2025	By:	/s/ Keeren Shah
		Name:	Keeren Shah
		Title:	Chief Financial Officer

2

EXHIBIT INDEX

Exhibit No.		Description
99.1		Tiziana Life Sciences LTD Press Release, dated July 21, 2025

3

FAQ

When will Gilat (GILT) release Q2 2025 earnings?

The company will publish its second-quarter 2025 results on Wednesday, August 6, 2025.

What time is Gilat's Q2 2025 conference call?

Management will host the call at 09:30 AM EST / 16:30 IST on August 6, 2025.

How can investors access the Gilat Q2 2025 webcast?

A live webcast will be available at https://www.veidan-conferencing.com/gilat; a replay remains online for 30 days.

What are the dial-in numbers for the Gilat earnings call?

US participants: 1-888-407-2553; international participants: +972-3-918-0609.

Who will present on Gilat's Q2 2025 earnings call?

CEO Adi Sfadia and CFO Gil Benyamini will review results and host Q&A.